2024-09-11 - Analysis Report
## ABBV Stock Analysis Report

**Company Overview:**  ABBV is a pharmaceutical company that develops, manufactures, and markets a wide range of medicines, including treatments for autoimmune diseases, cancer, and viral infections.

**1. Performance Comparison:**

ABBV has outperformed the S&P 500 (VOO) by **22.47%** as of the last data point. This represents a **72.04%** position relative to the historical performance range.

**2. Recent Price Movement:**

* **Closing Price:** $196.42
* **5-Day Moving Average:** $195.48
* **20-Day Moving Average:** $195.14
* **60-Day Moving Average:** $181.74

The stock price is currently above all three moving averages, suggesting a potential upward trend.

**3. Technical Indicators:**

* **RSI:** 48.57, indicating a neutral market sentiment, neither overbought nor oversold.
* **PPO:** -0.5, suggesting a slight bearish momentum.
* **Delta_Previous_Relative_Divergence:** 2.42, indicates a recent short-term upward trend.
* **Expected Return:** 13.21%, representing the potential maximum return over 5 years for current investment.

**4. Recent Earnings and Outlook:**

| Date | EPS | Estimated EPS |
|---|---|---|
| 2024-07-25 | 2.65 | 2.57 |
| 2024-04-26 | 2.31 | 2.26 |
| 2024-02-02 | 2.79 | 2.76 |
| 2023-10-27 | 2.95 | 2.86 |
| 2023-07-27 | 2.91 | 2.79 |

ABBV has consistently exceeded earnings expectations in the recent past. The most recent earnings report (2024-07-25) showed an EPS of 2.65, exceeding the estimated EPS of 2.57. This positive earnings trend suggests that ABBV is performing well financially and may continue to generate strong returns in the future.

**5. Overall Analysis:**

ABBV has demonstrated strong performance, outperforming the S&P 500 over the historical period. The current price movement suggests a potential upward trend. While technical indicators show mixed signals, the recent earnings report and positive earnings trend suggest a favorable outlook for the company. 

**6. Conclusion:**

ABBV appears to be a promising investment with potential for growth, backed by strong financial performance and a positive earnings track record. However, investors should consider the technical indicators and market conditions before making an investment decision. 
